The Role of Soluble HLA-G in the Vertical Transmission of Toxoplasma gondii
- Authors: Wang H.F.1,2, Jiang Y.Z.1, Ren L.Q.3, Liu X.B.1, Zhang H.X.1, Hu X.M.1,3
-
Affiliations:
- Department of Immunology, Binzhou Medical University
- Department of Immunology, Shandong College of Traditional Chinese Medicine
- Medical and Pharmaceutical Research Center, Binzhou Medical University
- Issue: Vol 53, No 2 (2019)
- Pages: 267-273
- Section: Molecular Cell Biology
- URL: https://journal-vniispk.ru/0026-8933/article/view/163884
- DOI: https://doi.org/10.1134/S002689331902016X
- ID: 163884
Cite item
Abstract
Soluble human leukocyte antigen G (sHLA-G) plays a key role in pregnancy through interaction with decidual natural killer (dNK) cell inhibitory receptors at the maternal-fetal interface. To demonstrate the possible role of sHLA-G during the pregnancy with Toxoplasma gondii infection, we compared the concentration of a murine functional homolog of sHLA-G, Qa-2, in T. gondii infected and non-infected pregnant C57BL/6 mice, and that of sHLA-G in BeWo culture supernatant. In addition, the levels of KIR2DL4 expressed on human dNK cells and NKG2A in pregnant mice were evaluated. We showed that T. gondii infection result in significant increase in the level of Qa-2 and NKG2A in pregnant mice. sHLA-G and KIR2DL4 in human samples were also significantly upregulated under the condition of T. gondii infection. The further treatment with sHLA-G antibody could reduce the expression level of KIR2DL4 which was upregulated by T. gondii infection. In summary, sHLA-G could upregulate the expression level of KIR2DL4 which lead to excessive immunological tolerance, and further contributed to T. gondii immunity escaping and affecting fetus via vertical transmission which may lead to adverse outcomes.
Keywords
About the authors
H. F. Wang
Department of Immunology, Binzhou Medical University; Department of Immunology, Shandong College of Traditional Chinese Medicine
Email: xue-mei-hu@163.com
China, Yantai, Shandong Province, 264003; Yantai, Shandong Province, 264003
Y. Z. Jiang
Department of Immunology, Binzhou Medical University
Email: xue-mei-hu@163.com
China, Yantai, Shandong Province, 264003
L. Q. Ren
Medical and Pharmaceutical Research Center, Binzhou Medical University
Email: xue-mei-hu@163.com
China, Yantai, Shandong Province, 264003
X. B. Liu
Department of Immunology, Binzhou Medical University
Email: xue-mei-hu@163.com
China, Yantai, Shandong Province, 264003
H. X. Zhang
Department of Immunology, Binzhou Medical University
Email: xue-mei-hu@163.com
China, Yantai, Shandong Province, 264003
X. M. Hu
Department of Immunology, Binzhou Medical University; Medical and Pharmaceutical Research Center, Binzhou Medical University
Author for correspondence.
Email: xue-mei-hu@163.com
China, Yantai, Shandong Province, 264003; Yantai, Shandong Province, 264003
Supplementary files
